Article Details

GSK's asthma drug Nucala meets main goal in study on treating smoker's lungs

Retrieved on: 2024-09-07 00:55:27

Tags for this article:

Click the tags to see associated articles and topics

GSK's asthma drug Nucala meets main goal in study on treating smoker's lungs. View article details on hiswai:

Excerpt

Nucala is a monoclonal antibody that inhibits interleukin-5, which helps regulate eosinophils, a type of white blood cell that causes inflammation ...

Article found on: www.pharmalive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo